@article{6afb07eae0c7449bb314fb5b90a3ff1d,
title = "Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia",
keywords = "Animals, Antimetabolites, Antineoplastic/pharmacology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Deoxycytidine/analogs & derivatives, Disease Management, Disease Models, Animal, Drug Evaluation, Preclinical, Gene Rearrangement, Genetic Predisposition to Disease, Humans, Infant, Myeloid-Lymphoid Leukemia Protein/genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Gemcitabine",
author = "Priscilla Wander and Cheung, {Laurence C.} and Pinhanҫos, {Sandra S.} and Luke Jones and Mark Kerstjens and Arentsen-Peters, {Susan T.C.J.M.} and Sajla Singh and Chua, {Grace Alyssa} and Castro, {Patricia Garrido} and Pauline Schneider and Dolman, {M. Emmy M.} and Bianca Koopmans and Molenaar, {Jan J.} and Rob Pieters and Zwaan, {C. Michel} and Kotecha, {Rishi S.} and Stam, {Ronald W.}",
note = "Funding Information: Acknowledgements RSK is supported by a Fellowship from the National Health and Medical Research Council of Australia (NHMRC APP1142627). RSK and LCC are supported by the Children{\textquoteright}s Leukaemia and Cancer Research Foundation (CLCRF, Australia).",
year = "2020",
month = nov,
day = "1",
doi = "10.1038/s41375-020-0895-9",
language = "English",
volume = "34",
pages = "2898--2902",
journal = "Leukemia",
issn = "0887-6924",
number = "11",
}